C Christodoulides, P Dyson, D Sprecher, K … - Journal of Clinical Endocrinology & Metabolism, 2009 - Endocrine Soc 1 Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital,
Oxford, UK. 2 NIHR Oxford Biomedical Research Centre, ORH Trust, Churchill
Hospital, Oxford, UK 3 Cardiovascular and Urogenital Centre for Excellence ... Cited by 1 - Related articles - All 2 versions
M Rydén - Cellular and Molecular Life Sciences, 2009 - Springer Abstract Fibroblast growth factor 21 (FGF21) has been proposed as a novel
putative therapeutic agent in type 2 diabetes. A large amount of data,
predominantly obtained from murine models but also from non-human primates, ... Cited by 1 - Related articles - All 2 versions
S Bhatnagar, HA Damron, FB Hillgartner - Journal of Biological Chemistry, 2009 - ASBMB Previous studies have shown that administration of fibroblast growth factor-19
(FGF-19) reverses diabetes, hepatic steatosis, hyperlipidemia, and adipose
accretion in animal models of obesity. To investigate the mechanism for ... Cited by 1 - Related articles - All 3 versions
J Xu, S Stanislaus, N Chinookoswong, YY Lau, … - American Journal of Physiology- Endocrinology And …, 2009 - Am Physiological Soc Recombinant fibroblast growth factor (FGF)21 has antihyperglycemic,
antihyperlipidemic, and antiobesity effects in diabetic rodent and monkey
models. Previous studies were confined to measuring steady-state effects of ... Related articles - All 3 versions
C Christodoulides, P Dyson, D Sprecher, K … - Journal of Clinical Endocrinology & Metabolism, 2009 - Endocrine Soc Context: Murine fibroblast growth factor (FGF) 21 is a nutritionally regulated
hormone secreted by the liver principally in response to peroxisome
proliferator-activated receptor- (PPAR ) activation, which plays a critical ... Related articles
PIN DIABETES - mc.vanderbilt.edu There are few methodologies that have done more to advance our understanding of
insulin action in humans and animals than the hyperinsulinemic- euglycemic clamp
(henceforth referred to as the insulin clamp or clamp). The clamp was first ... Related articles - View as HTML
K Iizuka, J Takeda, Y Horikawa - FEBS letters, 2009 - Elsevier Fibroblast growth factor 21 (FGF21) has beneficial effects of improving the
plasma glucose and lipid profiles in diabetic rodents. Here, we investigated
carbohydrate response element binding protein (ChREBP) involvement in the ... Related articles - All 9 versions
I Pagel-Langenickel, J Bao, L Pang, MN Sack - Endocrine Reviews, 2009 - Endocrine Soc Multiple organs contribute to the development of peripheral insulin resistance,
with the major contributors being skeletal muscle, liver, and adipose tissue.
Because insulin resistance usually precedes the development of type 2 ...
T Uebanso, Y Taketani, M Fukaya, K Sato, Y … - American Journal of Physiology- Endocrinology And …, 2009 - Am Physiological Soc The mechanism by which replacement of some dietary carbohydrates with protein
during weight loss favors lipid metabolism remains obscure. In this study, we
investigated the effect of an energy-restricted, ... Related articles - All 4 versions
E Berglund, 2009 - etd.library.vanderbilt.edu Page 1. NOVEL INSIGHTS INTO METABOLIC REGULATION BY GLUCAGON RECEPTOR ACTIVATION –
INDUCTION OF HEPATIC ENERGY-DEPLETION AND AMPK SIGNALING By Eric Berglund ... Related articles - View as HTML - All 2 versions
